These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Adjunctive adjuvant or neoadjuvant chemotherapy for locally advanced bladder cancer: a critical appraisal of the present status. Walther PJ Semin Urol; 1993 Nov; 11(4):227-34. PubMed ID: 8290828 [No Abstract] [Full Text] [Related]
5. [Active studies on bladder carcinoma in the year 2004]. Rexer H Urologe A; 2004 Mar; 43(3):318-20. PubMed ID: 15045194 [No Abstract] [Full Text] [Related]
7. [Chemotherapy of bladder carcinoma. Current status and trends]. Block T Urologe A; 1994 Nov; 33(6):557-67. PubMed ID: 7817457 [TBL] [Abstract][Full Text] [Related]
8. Systemic chemotherapy in locally advanced and/or metastatic bladder cancer. Pectasides D; Pectasides M; Economopoulos T Cancer Treat Rev; 2006 Oct; 32(6):456-70. PubMed ID: 16935429 [TBL] [Abstract][Full Text] [Related]
9. [Adjuvant chemotherapy in carcinoma of the bladder: current results and prospects]. Ficorella C; Iavarone C; Tomao S; Felici A; Battisti G; Stio F; Guarnieri F; Brescia A; Marigliani M; Messinetti S G Chir; 1990; 11(11-12):650-1. PubMed ID: 2091728 [TBL] [Abstract][Full Text] [Related]
10. [Treatment of bladder cancer with cytostatic agents]. Steineck G; Wijkström H; Borghede G Lakartidningen; 1994 Feb; 91(5):397-404. PubMed ID: 8114569 [No Abstract] [Full Text] [Related]
12. Current status of bladder cancer protocols in the EORTC Genito-Urinary Group. Denis L; Pavone-Macaluso M; De Pauw M Prog Clin Biol Res; 1984; 162B():429-39. PubMed ID: 6390450 [TBL] [Abstract][Full Text] [Related]
13. Systemic chemotherapy of carcinoma of the urinary bladder. Maral J; Chamseddine N; Auclerc G; Jacquillat C Prog Clin Biol Res; 1984; 162B():107-12. PubMed ID: 6542216 [No Abstract] [Full Text] [Related]
14. Perspectives for progress in the treatment of superficial bladder cancer. The need for multi-institutional studies and the possible role of the EORTC Genito-Urinary Group. Pavone-Macaluso M; Serrette V Prog Clin Biol Res; 1989; 310():357-60. PubMed ID: 2672022 [No Abstract] [Full Text] [Related]
15. Survival and neo-adjuvant chemotherapy in invasive bladder cancer. Hall RR Prog Clin Biol Res; 1988; 269():569-77. PubMed ID: 3293072 [No Abstract] [Full Text] [Related]
16. Neoadjuvant chemotherapy for bladder transitional cell carcinoma: a new standard of care? Mazhar D; Ali N; Ngan S Future Oncol; 2007 Feb; 3(1):5-8. PubMed ID: 17280495 [No Abstract] [Full Text] [Related]
17. Intra-arterial chemotherapy for bladder cancer: its results and future role. Kato T; Sato K; Abe R; Moriyama M Prog Clin Biol Res; 1988; 269():551-67. PubMed ID: 3293071 [No Abstract] [Full Text] [Related]
18. Ongoing trials in bladder cancer conducted by the EORTC Genito-Urinary Tract Cancer Cooperative Group. De Pauw M Prog Clin Biol Res; 1988; 260():215-23. PubMed ID: 3283760 [No Abstract] [Full Text] [Related]
19. The role of systemic chemotherapy in advanced bladder cancer. van Groeningen CJ; Stoter G Prog Clin Biol Res; 1984; 153():381-93. PubMed ID: 6382283 [No Abstract] [Full Text] [Related]